KRAS and cancer: DMF has been shown to be cytotoxic in patient and mouse derived cancer cell lines from lung and colon adenocarcinoma with KRAS mutations, likely via effect on decreasing activity of the Nrf2/DJ-1 antioxidant pathway and contributing to cancer cell death (75, 76).